Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vijaya Diagnostic CentreBOM:543350 -0.76%87 3-Year ROIIC % is 13.85 as of Mar. 2026, which is 42% above its 10-year median of 9.75. GuruFocus rates BOM:543350 with a GF Score™ of 87/100 and a GF Value™ of ₹1,256.40 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 202 Medical Diagnostics & Research companies, Vijaya Diagnostic Centre ranks better than 62.87% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Vijaya Diagnostic Centre's 3-Year ROIIC % for the quarter that ended in Mar. 2026 was 13.85%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Vijaya Diagnostic Centre's 3-Year ROIIC % or its related term are showing as below:
BOM:543350's 3-Year ROIIC % is ranked better than 62.87% of 202
companies
in the Medical Diagnostics & Research industry
Industry Median: 0.385
vs BOM:543350: 13.85
Vijaya Diagnostic Centre (BOM:543350) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Vijaya Diagnostic Centre 3-Year ROIIC % Related Terms
Vijaya Diagnostic Centre 3-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:543350 vs TMO, DHR, IDXX: 3-Year ROIIC % Comparison
For the Diagnostics & Research subindustry, Vijaya Diagnostic Centre's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vijaya Diagnostic Centre 3-Year ROIIC % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Vijaya Diagnostic Centre's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Vijaya Diagnostic Centre's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Vijaya Diagnostic Centre (BOM:543350) has a 3-Year ROIIC % of 13.85 as of Mar. 2026. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Vijaya Diagnostic Centre and its competitors. This is 42% above median its historical median of 9.75. Over the past decade, Vijaya Diagnostic Centre's 3-Year ROIIC % has ranged from 6.20 to 35.12. According to the industry distribution chart, Vijaya Diagnostic Centre ranks #75 out of 202 companies in the Medical Diagnostics & Research industry, placing it in the top 37.1%.
Is Vijaya Diagnostic Centre's 3-Year ROIIC % too high?
Vijaya Diagnostic Centre's current 3-Year ROIIC % of 13.85 is 42% above median its 10-year median of 9.75. Over the past 10 years, this metric has ranged from a low of 6.20 to a high of 35.12. The Medical Diagnostics & Research industry median 3-Year ROIIC % is 0.39. Vijaya Diagnostic Centre's value of 13.85 is 3497.4% above this industry median. Based on the distribution chart, Vijaya Diagnostic Centre ranks #75 out of 202 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Vijaya Diagnostic Centre has a GF Score™ of 87/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vijaya Diagnostic Centre's 3-Year ROIIC % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Vijaya Diagnostic Centre ranks #75 out of 202 companies for 3-Year ROIIC %. This puts Vijaya Diagnostic Centre in the upper half of its industry. The industry median 3-Year ROIIC % is 0.39. Vijaya Diagnostic Centre's value of 13.85 is 3497.4% above this benchmark. Historically, Vijaya Diagnostic Centre's own 3-Year ROIIC % has ranged from 6.20 to 35.12 over the past decade. While the company's 10-year median is 9.75 vs. the industry median of 0.39, Vijaya Diagnostic Centre has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Medical Diagnostics & Research company?
The median 3-Year ROIIC % among Medical Diagnostics & Research companies is 0.39, based on 202 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vijaya Diagnostic Centre's current 3-Year ROIIC % of 13.85 is 3497.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Vijaya Diagnostic Centre and its competitors. For the Medical Diagnostics & Research industry, the median 3-Year ROIIC % is 0.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vijaya Diagnostic Centre's current 3-Year ROIIC % is 13.85, which is 42% above median its own 10-year median of 9.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vijaya Diagnostic Centre stock overvalued right now?
Based on GuruFocus' analysis, Vijaya Diagnostic Centre (BOM:543350) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹1,256.40, compared to a current price of ₹1,469.25 — trading 16.9% above its estimated fair value. The current 3-Year ROIIC % is 13.85, which is 42% above median its 10-year median of 9.75 and 3497.4% above the Medical Diagnostics & Research industry median of 0.39. Vijaya Diagnostic Centre's overall GF Score™ is 87/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Vijaya Diagnostic Centre (BOM:543350), the current 3-Year ROIIC % is 13.85 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vijaya Diagnostic Centre (BOM:543350) Overvalued in 2026?
Based on GuruFocus' analysis, Vijaya Diagnostic Centre stock appears to be overvalued.
The current stock price of ₹1,469.25 is trading 16.9% above its estimated GF Value™ of ₹1,256.40.
GuruFocus considers Vijaya Diagnostic Centre to be Modestly Overvalued.
Key valuation signals for BOM:543350:
3-Year ROIIC %: 13.85 (42% above median its 10-year median of 9.75)
GF Value™: ₹1,256.40 vs. price of ₹1,469.25 (16.9% above fair value)
Industry Position: 3497.4% above the Medical Diagnostics & Research median (#75 of 202)
No single metric tells the full story. See the BOM:543350 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vijaya Diagnostic Centre Ltd operates a diagnostic chain in Southern India. The company offers a one-stop solution for pathology and radiology testing services. It provides routine tests, specialized pathology tests, basic tests, and radiology tests. The company also offers a broad spectrum of customized health and wellness packages to its customers. The company's revenue comes from many diagnostic centers, where high-volume sales drive its earnings. The Company operates within India. The company's operations fall within a single business segment, which is Diagnostic Services.
87GF Score
Get the complete analysis for BOM:543350
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543350 has been successfully added to your 
